Takeda inks deal worth $670M with Orifarm

Japan based Takeda Pharmaceutical Company Limited has announced that it has entered into an agreement to divest a p...

April 29, 2020 | Wednesday | News
Terumo donates $2.4 M for COVID-19 fight

As the world joins together to support healthcare workers and others on the front lines providing critical care to patie...

April 28, 2020 | Tuesday | News
Astellas acquires Nanna Therapeutics for £12 M

Japan based Astellas Pharma Inc. and UK based Nanna Therapeutics Limited have announced that Astellas has acquired Nanna...

April 27, 2020 | Monday | News
NEC designs blueprints for COVID-19 vaccines using AI

Japan based NEC Corporation has announced analysis results from efforts using AI prediction platforms to design blueprin...

April 24, 2020 | Friday | News
Esperion & Otsuka to develop treatment for hypercholesterolemia

US based Esperion has announced that the company has entered into a collaboration agreement with Otsuka Pharmaceutic...

April 23, 2020 | Thursday | News
Daiichi Sankyo to donate $1M for COVID-19 relief fund

Daiichi Sankyo Company, Limited has announced that, through the Japan Center for International Exchange, it will make a ...

April 17, 2020 | Friday | News
Fujifilm accelerates favipiravir production for COVID-19 treatment

Fujifilm is ramping up production of its antiviral treatment drug favipiravir, one of many approved drugs being tested...

April 16, 2020 | Thursday | News
Daiichi Sankyo commences gene therapy research to restore vision

Japan based Daiichi Sankyo Company, Limited, Mitsubishi UFJ Capital Co., Ltd. and Nagoya Institute of Technology ha...

April 14, 2020 | Tuesday | News
Takeda and CSL Behring to Develop Potential COVID-19 Hyperimmune Therapy

Takeda and CSL Behring, a provider of plasma-derived and recombinant therapies based in King of Prussia, PA, on 6 April ...

April 10, 2020 | Friday | News
Chugai starts Ph III trial of Actemra for COVID-19 pneumonia

Japan based Chugai Pharmaceutical Co., Ltd. has announced that it is working to start a Phase III clinical trial in Japa...

April 10, 2020 | Friday | News
Jolly Good, NCCBTR collaborate for VR Therapeutics

Japanese startup Jolly Good Inc. and the National Center for Cognitive Behavior Therapy and Research (NCCBTR) announced ...

April 6, 2020 | Monday | News
SanBio, Ocumension enter into biz alliance for treating eye diseases

Japan based SanBio and Hong Kong based Ocumension have entered into a business alliance for the research, development an...

April 7, 2020 | Tuesday | News
Genesis Healthcare unveils new detection test for COVID-19

Genesis Healthcare Co., Japan's leading genetic testing and research company, today announced the launch of a real-time ...

April 3, 2020 | Friday | News
Japan Coronavirus COVID-19 (2019-nCoV) Pandemic Dashboard : Daily Confirmed Cases

Daily New Confirmed Cases : Japan   ...

April 3, 2020 | Friday | News
Japan's MEXT awarded the A-PRAS certificate to Impact Science

Japan’s Ministry of Education, Culture, Sports, Science and Technology (MEXT) awarded Impact Science with the Accr...

April 2, 2020 | Thursday | News
Daiichi Sankyo, Ultragenyx partner for gene therapy manufacturing technology

Japan based Daiichi Sankyo Company, Limited has announced that it has entered into a strategic partnership with US based...

April 1, 2020 | Wednesday | News
GHIT Fund announces new investment of 3.29 B Yen

Japan based Global Health Innovative Technology (GHIT) Fund has announced a total of 3.29 billion yen (US$30 m...

April 1, 2020 | Wednesday | News
Hitachi to establish Lumada Data Science lab

Japan based Hitachi, Ltd. on 30 March 2020 announced that on April 1, it will establish the "Lumada(1) Data Science Lab....

March 31, 2020 | Tuesday | News
Daiichi Sankyo ends influenza vaccine sales deal with Kitasato

Japan based Daiichi Sankyo Company, Limited and Kitasato Pharmaceutical Industry Co., Ltd. have announced the terminatio...

March 30, 2020 | Monday | News
CG Oncology inks agreement with Kissei Pharma for $40M

US based CG Oncology, Inc. has announced an exclusive license, development and commercialization agreement with Japanese...

March 27, 2020 | Friday | News
Daiichi Sankyo receives approval for new breast cancer drug

Japan based Daiichi Sankyo Company, Limited has announced the approval of ENHERTU® (trastuzumab deruxtecan), a HER2 ...

March 26, 2020 | Thursday | News
CytomX, Astellas to find cure for cancer

US based CytomX Therapeutics and Japan based Astellas Pharma have entered into a strategic collaboration agreement focus...

March 25, 2020 | Wednesday | News
Diagnostic biomarker for acute adult T-cell cancers discovered

A study jointly conducted by Dean and Professor Takuya Fukushima, M.D., Ph.D., Graduate School of Health Sciences, Unive...

March 23, 2020 | Monday | News
Eisai to launch digital tool to assess brain health

Japan based company Eisai will launch "NouKNOWTM" (pronounced "NOH-NOH"), a new digital tool (non-medical device) for se...

March 24, 2020 | Tuesday | News
Gifu University, Astellas to create new treatments for bacterial infections

Japan based Gifu University and Astellas Pharma Inc. have announced that the parties have established, inside Gifu Unive...

March 23, 2020 | Monday | News